Jamal Tazi

This inventor holds 39 USPTO granted patents and 15 published patent applications, plus 20 CIPO patents and 24 EPO patents, primarily in Quinoline Derivatives. Top assignees: Institut Curie, Centre National De La Recherche Scientifique, Universitè De Montpellier. Active years: 2011-2026.

USPTO Granted Patents = 39 (Patent Applications = 15)

% Patents Active = 100.0

CIPO Patents = 20 (Patent Applications = 10)

EPO Patents = 24 (Patent Applications = 43)

Average Co-Inventor Count = 5.4

ph-index = 8

Forward Citations = 159(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

patents

36 out of 297

Universitè De Montpellier

Université Montpellier 2 Sciences Et Techniques

patents

6. 1 out of 123

Centre National De La Recherche Scientifique

patents

7. 1 out of 1

The University of Montpellier 2 Science and Techniques

patent

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Quinoline Derivatives

RNA Virus Infection

Cancer Treatment

Inflammatory Diseases

miRNA-124

Therapeutic Agents

Chemical Molecules

P53 Expression

Indole Compounds

Splicing Anomalies

AIDS Treatment

Pharmaceutical Compositions

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12617756 - Substituted imidazolidines for treating a RNA virus infection (2026-05-05),

2. 12479802 - Phenyl-n-quinoline derivatives for treating a RNA virus infection (2025-11-25),

3. 12421206 - Aryl-n-aryl derivatives for treating a RNA virus infection (2025-09-23),

4. 12247018 - Aryl-n-aryl derivatives for treating a RNA virus infection (2025-03-11),

5. 12202804 - In vitro or ex vivo methods for screening a quinoline derivative (2025-01-21),

6. 12084422 - Phenyl-n-quinoline derivatives for treating a RNA virus infection (2024-09-10),

7. 11992499 - Quinoline derivatives for use in the treatment of inflammation diseases (2024-05-28),

8. 11739073 - Aryl-n-aryl derivatives for treating a RNA virus infection (2023-08-29),

9. 11649211 - Use of quinoline derivatives for the treatment of inflammatory diseases (2023-05-16),

10. 11649210 - Use of quinoline derivatives for the treatment of inflammatory diseases (2023-05-16),

11. 11441181 - miRNA-124 as a biomarker (2022-09-13),

12. 11427566 - Compounds useful for treating cancer (2022-08-30),

13. 11014918 - Compounds and pharmaceutical compositions containing at least one of the compounds (2021-05-25),

14. 10981874 - Use of quinoline derivatives for the treatment of inflammatory diseases (2021-04-20),

15. 10975063 - Compound, and production method thereof, and methods of treatment using the compound (2021-04-13),

Title: The Innovative Journey of Inventor Jamal Tazi

Introduction: Jamal Tazi, a visionary inventor hailing from Clapiers, France, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Jamal Tazi's latest patents include a revolutionary smart home automation system that integrates artificial intelligence for enhanced efficiency and a sustainable energy-saving device designed to reduce carbon footprint.

Career Highlights: With a career spanning over two decades, Jamal Tazi has established himself as a pioneer in the field of renewable energy technologies. His innovative solutions have garnered international recognition and have been instrumental in shaping the future of sustainable living.

Collaborations: Throughout his career, Jamal Tazi has collaborated with leading research institutions and universities to further advance his inventions. His partnerships with top engineers and scientists have resulted in cutting-edge technological developments that have set new industry standards.

Conclusion: Jamal Tazi's relentless passion for innovation and commitment to creating a more sustainable world have solidified his position as a trailblazing inventor. His remarkable contributions continue to inspire future generations of inventors to push the boundaries of what is possible in the realm of technology.